short-term investments of approximately $14,775,000, a decrease of
approximately $4,086,000 from December 31, 2007. Approximately $4,075,000
of the decrease relates to a net loss incurred during the period after
deducting items not involving cash, a source of approximately $2,489,000 in
net changes in non-cash working capital relating primarily to the
collection of accounts receivable from Edwards, an investment in the TMR
business of $2,089,000 relating to the payment to Edwards of earn-out
purchase consideration, and an investment of approximately $436,000 in
property, plant and equipment.
As at March 31, 2008 there were a total of 24,533,982 common shares
(26,094,395 on a fully diluted basis) and no preferred shares outstanding.
As at March 31, 2008 a total of 1,560,413 stock options were outstanding
under the Company's employee stock option plan.
Novadaq will host a conference call on Monday, May 12, 2008 at 10:00
a.m. EST to discuss the financial results for the first quarter ended March
31, 2008. To access the conference call by telephone, dial 416-644-3422 or
1-800-731-5319. Please connect approximately ten minutes prior to the
beginning of the call to ensure participation. The conference call will be
archived for replay until May 19, 2008 at midnight. To access the archived
conference call, dial 416-640-1917 or 1-877-289-8525 and enter the
reservation number 21270216 followed by the number sign.
A live audio webcast of the conference call will be available at
http://www.novadaq.com. Please connect at least ten minutes prior to the
conference call to ensure adequate time for any software download that may
be required to join the webcast. The webcast will be archived at the above
website for 365 days.
For complete financial results, please see our filings at http://www.sedar.com.
Page: 1 2 3 4 5 6 7 8 9 10 11 Related medicine news :1
|SOURCE Novadaq Technologies Inc.|
Copyright©2008 PR Newswire.
All rights reserved
. Novadaq Resumes Normal Business Operations by Securing ICG for SPY2
. Novadaq launches PINPOINT: Companys first minimally invasive imaging system3
. Novadaq announces third quarter 2007 conference call and webcast4
. Novadaq to present at Piper Jaffray Healthcare Conference5
. Novadaq to present at BMO Healthcare Conference6
. Novadaqs SPY Imaging System named Product of the Year by Frost and Sullivan7
. Novadaqs SPY System receives clearance for use in organ transplant surgery8
. Novadaq Data Presented at 2008 Society of Thoracic Surgeons Meeting9
. NOVADAQs SPY System to be Featured During Live Broadcast of Robotic Surgery10
. Novadaq to present at Cowen Healthcare Conference11
. Novadaq to hold fiscal 2007 year-end and fourth quarter results conference call and webcast